Wellington Management Group LLP Reduces Stock Position in Acadia Healthcare Company, Inc. $ACHC

Wellington Management Group LLP cut its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 36.9% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,726,246 shares of the company’s stock after selling 3,346,696 shares during the period. Wellington Management Group LLP owned about 6.15% of Acadia Healthcare worth $169,096,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the business. EverSource Wealth Advisors LLC increased its stake in Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after acquiring an additional 497 shares during the last quarter. Wells Fargo & Company MN lifted its stake in shares of Acadia Healthcare by 208.9% in the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after purchasing an additional 1,510 shares during the last quarter. Allworth Financial LP purchased a new position in shares of Acadia Healthcare in the 2nd quarter worth approximately $45,000. Global Retirement Partners LLC bought a new position in shares of Acadia Healthcare during the 2nd quarter valued at approximately $68,000. Finally, Caitong International Asset Management Co. Ltd raised its holdings in Acadia Healthcare by 4,264.8% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock valued at $76,000 after buying an additional 5,203 shares during the period.

Analyst Ratings Changes

A number of research analysts have weighed in on ACHC shares. UBS Group boosted their price objective on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research report on Thursday, July 9th. Guggenheim lifted their price target on shares of Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a research note on Thursday, July 30th. Royal Bank Of Canada upped their price target on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a report on Monday, May 4th. KeyCorp raised their price objective on shares of Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 14th. Finally, Raymond James Financial upgraded Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price for the company in a research report on Monday, May 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $29.85.

Acadia Healthcare Trading Down 3.5%

Shares of ACHC opened at $27.56 on Tuesday. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57. The firm has a market capitalization of $2.57 billion, a price-to-earnings ratio of -2.21, a PEG ratio of 9.20 and a beta of 0.64. The company has a 50-day moving average of $30.51 and a 200 day moving average of $26.25. Acadia Healthcare Company, Inc. has a 1-year low of $11.43 and a 1-year high of $35.83.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.03. The business had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The company’s revenue for the quarter was down .4% on a year-over-year basis. During the same quarter last year, the firm posted $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, research analysts expect that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.